(Stroke. 1999;30:613-618.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Neuroscience and Neurology (A.I., S.H.) and A.I. Virtanen Institute (R.P.), Kuopio University; and Department of Pathology (A.I.), Division of Diagnostic Services, Chromosome and DNA Laboratory (H.S., M.A.), and Department of Neurology (S.H.), Kuopio University Hospital, Kuopio, Finland.
Correspondence to Irina Alafuzoff, MD, PhD, Departments of Neuroscience and Neurology and Pathology, Kuopio University, P-O-B 1627, Fin 70 211 Kuopio, Finland. E-mail irina.alafuzoff{at}uku.fi
Background and
PurposeThis study was conducted to analyze the
association between reported risk factors for Alzheimer's
disease, apolipoprotein E
4 allele, and
cardiovascular disease and neuropathological changes
essential for the diagnosis of Alzheimer's disease.
MethodsOur data are based on clinical and postmortem evaluations of a cohort of nondemented (n=118) and demented (n=107) individuals. A cardiovascular index was calculated at autopsy to estimate the extent of cardiovascular disease. Neuropathological lesions such as senile/neuritic plaques, neurofibrillary tangles, ß-amyloid load, cerebral amyloid angiopathy, and the load of paired helical filaments were determined.
ResultsThe aforementioned neuropathological lesions did
not show any positive significant correlation with
cardiovascular index. In contrast, the extent of
Alzheimer's lesions was significantly higher in those
nondemented and demented patients carrying the apolipoprotein E
4
allele than in those without this allele.
ConclusionsOur results demonstrate that the apolipoprotein
E
4 allele, but not cardiovascular disease,
indeed influences the extent of Alzheimer's lesions seen in
the brain tissue of demented patients as well as
asymptomatic controls.
Key Words: aged Alzheimer's disease apolipoproteins risk factors
This article has been cited by other articles:
![]() |
L. Aho, J. Jolkkonen, and I. Alafuzoff {beta}-Amyloid Aggregation in Human Brains With Cerebrovascular Lesions Stroke, December 1, 2006; 37(12): 2940 - 2945. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Buerger, M. Ewers, T. Pirttila, R. Zinkowski, I. Alafuzoff, S. J. Teipel, J. DeBernardis, D. Kerkman, C. McCulloch, H. Soininen, et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease Brain, November 1, 2006; 129(11): 3035 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bhargava, M. F. Weiner, L. S. Hynan, R. Diaz-Arrastia, and A. M. Lipton Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol, June 1, 2006; 19(2): 78 - 82. [Abstract] [PDF] |
||||
![]() |
M. S. Beeri, M. Rapp, J. M. Silverman, J. Schmeidler, H. T. Grossman, J. T. Fallon, D. P. Purohit, D. P. Perl, A. Siddiqui, G. Lesser, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers Neurology, May 9, 2006; 66(9): 1399 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Honig, M.-X. Tang, S. Albert, R. Costa, J. Luchsinger, J. Manly, Y. Stern, and R. Mayeux Stroke and the Risk of Alzheimer Disease Arch Neurol, December 1, 2003; 60(12): 1707 - 1712. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |